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Class switch recombination (CSR) is an Ig gene 
diversification reaction that alters the Ig effec-
tor function while retaining antibody specific-
ity. During CSR, one constant region gene   
is exchanged for another by a deletional re-
combination reaction between switch regions, 
which are highly repetitive DNA sequences 
that precede constant region genes (Chaudhuri 
et al., 2007; Stavnezer et al., 2008). CSR occurs 
in the G1 phase of the cell cycle and proceeds 
through  obligate  double-strand  break  (DSB) 
intermediates (Petersen et al., 2001; Rada et al., 
2002). The reaction is initiated by activation-
induced cytidine deaminase (AID), an enzyme 
that deaminates cytidine residues in single-
stranded switch region DNA that is exposed 
during Ig transcription (Petersen-Mahrt et al., 
2002; Bransteitter et al., 2003; Chaudhuri et al., 
2003; Dickerson et al., 2003; Pham et al., 2003; 
Ramiro et al., 2003). AID produces multiple 
lesions in switch DNA, and the resulting U/G 
mismatches are processed to DSBs via the base 
excision and mismatch repair pathways (Catalan 
et al., 2003; Schrader et al., 2005; Stavnezer   
et al., 2008).
There are several ways to resolve switch re-
gion DSBs. For example, a single DSB can be 
repaired by religation, or two paired DSBs 
within a single switch region can be ligated   
together  to  produce  an  intra–switch  region   
deletion (ISD; Dudley et al., 2002). Alterna-
tively, synapsis and ligation of paired DSBs in 
two different switch regions leads to produc-
tive CSR (Stavnezer et al., 2008). Finally, in 
rare instances, an Ig DSB can be joined to a 
DSB on a heterologous chromosome to pro-
duce a translocation (Ramiro et al., 2004, 2006; 
Franco et al., 2006).
Switch region DSBs occur during G1, and 
they are ligated by either classical nonhomolo-
gous end joining (C-NHEJ; Manis et al., 2002; 
Lieber, 2008; Stavnezer et al., 2008) or alter-
native nonhomologous end joining (A-NHEJ; 
Yan et al., 2007; Haber, 2008; Boboila et al., 
2010a,b). C-NHEJ is an evolutionarily conserved 
pathway that utilizes Ku70/80 and DNA-PKcs 
for DSB recognition, and ligase IV–XRCC4 
for ligation (Lieber, 2008). Deletion of any of 
these factors impairs CSR (Callén et al., 2007; 
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Class switch recombination (CSR) diversifies antibodies by joining highly repetitive DNA 
elements, which are separated by 60–200 kbp. CSR is initiated by activation-induced 
cytidine deaminase, an enzyme that produces multiple DNA double-strand breaks (DSBs)  
in switch regions. Switch regions are joined by a mechanism that requires an intact DNA 
damage response and classical or alternative nonhomologous end joining (A-NHEJ). Among 
the DNA damage response factors, 53BP1 has the most profound effect on CSR. We explore 
the role of 53BP1 in intrachromosomal DNA repair using I-SceI to introduce paired DSBs  
in the IgH locus. We find that the absence of 53BP1 results in an ataxia telangiectasia 
mutated–dependent increase in DNA end resection and that resected DNA is preferentially 
repaired by microhomology-mediated A-NHEJ. We propose that 53BP1 favors long-range 
CSR in part by protecting DNA ends against resection, which prevents A-NHEJ–dependent 
short-range rejoining of intra–switch region DSBs.
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introduce site-specific DSBs in IgH in B lymphocytes under-
going CSR. We show that 53BP1 regulates the choice of 
end-joining pathways by interfering with resection, thereby 
favoring C-NHEJ.
RESULTS
IgH locus modification
To examine DSB repair in the context of IgH during CSR, 
we used sequential gene targeting in embryonic stem cells to 
introduce paired loxP and I-SceI sites in mouse chromosome 
12. One set of loxP and I-SceI sites was placed 3 of the in-
tronic enhancer E (Robbiani et al., 2008), and the second 
set of sites was introduced 3 of the IgG1 switch region, 95.9 kb 
downstream of the first. (IgHI-96k; Fig. S1, A and B). IgHI-96k 
mice showed normal B cell development and CSR to IgG1 
upon stimulation with LPS and IL-4 (Fig. S1, C and D).
In  contrast  to  the  DNA  lesions  introduced  by  AID, 
which can involve almost any cytidine residue in the switch 
region and are processed by a variety of different pathways 
(Stavnezer et al., 2008), the introduced loxP and I-SceI sites 
are in specific locations and are targeted by enzymes with 
well-defined mechanisms of action. Cre is a bacteriophage 
enzyme that mediates recombination between loxP sites via 
Holliday junction intermediates (Gopaul et al., 1998). Syn-
apsis between two molecules of Cre bound to separate loxP 
sites precedes and is required for catalysis (Van Duyne, 2001). 
Because synapsis is limiting in this reaction, the rate of re-
combination between loxP sites in mammalian cells express-
ing Cre is inversely proportional to the distance between the 
sites and can therefore serve as a measure of chromosome   
topology (Yu and Bradley, 2001; Egli et al., 2004). In con-
trast, I-SceI, a yeast-derived restriction meganuclease not nor-
mally present in the mouse genome, produces a single DSB 
in an 18-bp consensus sequence (Stoddard, 2005). When this 
enzyme is expressed in B lymphocytes containing an I-SceI 
site integrated into the IgH locus, DNA breaks are detectable 
at a high frequency at IgH, and translocations can form be-
tween I-SceI– and AID-generated breaks (Zarrin et al., 2007; 
Robbiani et al., 2008).
Recombination between loxP or I-SceI sites in IgHI-96k  
B lymphocytes should result in class switching from IgM to 
IgG1. However, IgH genes are allelically excluded (Chowdhury 
and Sen, 2004), with only 50% of the alleles encoding a 
functional variable region. Therefore, the maximum rate of 
Cre- or I-SceI–mediated CSR measured by IgG1 surface ex-
pression in heterozygous mice is 50% of the true recombina-
tion frequency.
Switching by Cre-mediated recombination
Although  the  mechanism  that  mediates  synapsis  between 
switch regions is poorly understood, chromosome conforma-
tion capture PCR experiments suggest that AID may con-
tribute  to  long-range  interactions  between  switch  regions 
(Wuerffel et al., 2007). To determine whether AID expres-
sion alters IgH topology sufficiently to change the rate of Cre-
mediated recombination between switch regions, we compared 
Soulas-Sprauel et al., 2007; Yan et al., 2007; Boboila et al., 
2010a,b).  C-NHEJ  ligates  DSBs  with  little  or  no  micro-
homology and appears to be the dominant pathway involved 
in CSR, based on the physiological predominance of blunt or 
small microhomology switch joins (Yan et al., 2007; Boboila 
et al., 2010a,b). In contrast, little is known about the factors 
that mediate A-NHEJ (Haber, 2008). However, this is a ro-
bust pathway that makes extensive use of junctional micro-
homologies and can reconstitute up to 20–50% of CSR in 
the absence of C-NHEJ (Yan et al., 2007; Boboila et al., 
2010a,b). A-NHEJ appears to be kinetically slower than C-
NHEJ and mediates many of the translocations that are rare 
byproducts of V(D)J recombination and CSR (Zhu et al., 
2002; Han and Yu, 2008; Wang et al., 2008, 2009; Xie et al., 
2009; Boboila et al., 2010b).
DSBs incurred during CSR activate the DNA damage 
response, as indicated by the accumulation of foci of Mre11/
Rad50/Nbs1 (MRN), H2AX, and 53BP1 on the IgH locus 
during CSR (Petersen et al., 2001; Reina-San-Martin et al., 
2003). DNA damage response factors are also required for   
efficient CSR. Deficiency in any of these or ataxia telangiec-
tasia mutated (ATM), a key mediator of the DNA damage 
response, leads to inefficient switching and concomitant   
accumulation of DNA damage on chromosome 12 (Reina-
San-Martin et al., 2004; Franco et al., 2006; Ramiro et al., 
2006; Jankovic et al., 2007). Among DNA damage response 
factors, the most pronounced defect in CSR occurs upon loss 
of 53BP1, a chromatin binding protein that is also an ATM 
and DNA-PKcs substrate (DiTullio et al., 2002; Manis et al., 
2004; Ward et al., 2004; Callén et al., 2007). Similarly, the 
absence of 53BP1 leads to a joining defect between distal 
DSBs  during  V(D)J  recombination  and  a  reduced  rate   
of  transchromosomal  fusions  of  deprotected  telomeres 
(Difilippantonio et al., 2008; Dimitrova et al., 2008). In con-
trast, ISDs and chromosome translocations, both of which 
appear to be mediated primarily by A-NHEJ, are either in-
creased or not affected by the loss of 53BP1 (Ramiro et al., 
2006; Reina-San-Martin et al., 2007). In addition, overex-
pression of a dominant-negative fragment of 53BP1 enhances 
homologous recombination (HR), as determined using a re-
porter substrate (Xie et al., 2007).
Several nonmutually exclusive models have been pro-
posed to account for the effects of 53BP1 on CSR, V(D)J   
recombination,  HR,  telomere  fusion,  and  chromosome 
translocation. 53BP1 may enhance synapsis and long-range 
interactions between two distal DSBs (Manis et al., 2004; 
Ward et al., 2004; Reina-San-Martin et al., 2007), possibly 
by altering local chromatin structure (Difilippantonio et al., 
2008) or increasing chromatin mobility (Dimitrova et al., 
2008). Alternatively, it may regulate repair by favoring one 
end-joining pathway or another, and thereby control the rel-
ative importance of microhomology in the joining process. 
However, there is little direct experimental data to support 
these ideas.
In this paper, we report experiments that investigate   
the function of 53BP1 using the I-SceI meganuclease to   JEM VOL. 207, April 12, 2010 
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IL-4, and infected with retroviruses encoding I-SceI or an 
inactive form of the enzyme I-SceI* (Fig. S2). Switching to 
IgG1 by retrovirally infected B cells was initially measured by 
flow cytometry (Fig. 2 B).
In contrast to Cre, I-SceI mediated CSR was ineffi-
cient in IgHI-96kAID/ B cells, with a mean recombination   
frequency of 0.54% 3 d after retroviral infection (five inde-
pendent experiments; Fig. 2 C and Table S1). The observed 
rate of I-SceI–induced CSR was somewhat lower than the 
rate obtained in B cells derived by RAG-blastocyst comple-
mentation (Zarrin et al., 2007). However, our experiments 
differ from previous experiments in several respects: AID was 
deleted and switch regions were present in our experiments, 
also, we used only a single I-SceI site in each location as   
opposed to two I-SceI sites, which doubles the number   
of breaks.
To determine whether loss of 53BP1 affects the joining 
efficiency  of  I-SceI  breaks,  we  assayed  IgHI-96kAID/ 
53BP1/ B cells. In contrast to Cre, where we observed no 
effects of 53BP1 deficiency, the I-SceI recombination fre-
quency was significantly reduced in IgHI-96kAID/53BP1/ 
B cells to 0.31% (five independent experiments; P = 0.0037; 
Fig. 2 C and Table S1). To obtain an independent measure 
of recombination frequency, we examined joining between 
I-SceI sites by sample dilution PCR. In agreement with the 
Cre-induced CSR in AID-deficient IgHI-96k B cells and con-
trol IgHI-96k B cells (Fig. 1).
B cells were stimulated with LPS and IL-4, and infected 
with  a  Cre-encoding  retrovirus  or  an  inactive  retrovirus 
Cre*. Infected cells were identified by GFP expression and 
CSR was measured by flow cytometry. Cre expression in 
AID-sufficient  IgHI-96k  B  lymphocytes  increased  CSR  to 
IgG1 from 3.8 to 14.4% and from 16.2 to 32.2% at 72 and 96 h 
after stimulation, respectively (Fig. 1 B). However, the rate 
of CSR in IgHI-96k B cells was similar in the presence or   
absence of AID 96 h after stimulation (Fig. 1, B and C).
To determine whether the loss of 53BP1 alters the effi-
ciency of Cre-mediated CSR, we compared the frequency 
of  recombination  between  IgHI-96kAID/53BP1/  and 
IgHI-96kAID/ B cells. We found that CSR in Cre-infected 
IgHI-96kAID/53BP1/ B cells was indistinguishable from 
53BP1-proficient cells (Fig. 1, C and D). We conclude that 
neither AID nor 53BP1 alters the overall structure of the IgH 
locus sufficiently to change the rate of synapsis between the 
IgHI-96k loxP sites.
I-SceI endonuclease–induced CSR
To further investigate the role of 53BP1 in CSR, we made 
use of I-SceI, which produces DSBs independently of syn-
apsis. IgHI-96kAID/ B cells were stimulated with LPS and   
Figure 1.  Cre recombinase induces efficient CSR to IgG1 independently of AID and 53BP1. (A) Schematic representation of the IgHI-96k allele  
(top) and the Cre-induced recombinant that encodes IgG1 (bottom). LoxP sites are indicated as red triangles, and I-SceI sites are indicated as blue circles. 
(B) Representative flow cytometry experiments showing CSR to IgG1 of IgHI-96k B cells infected with retroviruses encoding Cre or catalytically inactive Cre*. 
IgG1 expression was analyzed at 72 and 96 h after LPS and IL-4 stimulation. (C) Experiment as in B but for IgHI-96kAID/ and IgHI-96kAID/53BP1/  
B cells analyzed at 96 h after LPS and IL-4 stimulation. (D) Graph shows the results of three independent flow cytometry experiments measuring CSR to 
IgG1 after Cre infection of IgHI-96AID/ and IgHI-96kAID/53BP1/ B cells. The means are shown as horizontal lines. FSC, forward scatter.858 53BP1 influences end-joining pathway choice | Bothmer et al.
I-SceI  sites  from  IgHI-96kAID/53BP1/  B  cells  and 
IgHI-96kAID/ controls. Precise joining between I-SceI sites 
yields a 336-nt PCR product (Fig. 3 A), which was the pre-
dominant species in control IgHI-96kAID/ B cells (Fig. 3 B). 
End processing results in lower molecular weight species, which 
can be scored directly by counting the number of products that 
run ≤300 nt (i.e., more than 30 nt total end resection). The 
loss of 53BP1 resulted in an overall increase in the number of 
PCR products, with lower than expected molecular weight to 
51.6% of all products. (P = 0.0001; Fig. 3 C and Table S3).
The precise molecular structure of the joins was deter-
mined by sequencing. Although the mean extent of end 
processing was 34.7 nt in IgHI-96kAID/ B cells, it was 66.8 
nt in the absence of 53BP1 (P = 0.012; Fig. 3 D and Table S4). 
Consistent with the idea that ends are more frequently pro-
cessed in the absence of 53BP1, the number of precise joins 
that reconstituted the I-SceI site also decreased from 30.9 
to 13.3% in 53BP1/ B cells (P = 0.0041; Fig. 3 E and   
flow cytometry analysis, we found that the joining efficiency 
in stimulated IgHI-96kAID/ B lymphocytes was signifi-
cantly reduced from 0.76 to 0.48% in the absence of 53BP1   
(P = 0.0002; Fig. 2 D and Table S2). We conclude that loss 
of 53BP1 decreases the efficiency of recombination between 
I-SceI sites in IgHI-96kAID/ B cells; however, the effect is 
far less penetrant than it is for CSR.
53BP1 prevents processing of broken ends
53BP1 has been implicated in regulating the choice between 
HR and NHEJ DNA repair pathways in the S or G2 phase 
of the cell cycle. CSR does not appear to involve HR and   
occurs in the G1 phase of the cell cycle (Petersen et al., 2001). 
Nevertheless, CSR-induced DSBs can be joined by two dif-
ferent pathways: C-NHEJ or A-NHEJ (Yan et al., 2007;   
Boboila et al., 2010a,b).
To determine whether 53BP1 affects the choice between 
C-NHEJ and A-NHEJ, we characterized the joins between   
Figure 2.  Loss of 53BP1 decreases the joining efficiency of two distal I-SceI–induced DSBs. (A) Schematic representation of the IgHI-96k allele 
(top) and the I-SceI–induced recombinant that encodes IgG1 (bottom). LoxP sites are indicated as red triangles, and I-SceI sites are indicated as blue  
circles. (B) Representative flow cytometry experiments showing CSR to IgG1 of IgHI-96kAID/ and IgHI-96kAID/53BP1/ B cells 72 h after the first  
infection with an I-SceI–encoding retrovirus. (C) Graph shows the results of five independent flow cytometry experiments, with each dot representing an 
individual experiment. The p-value was calculated using a two-tailed paired Student’s t test. The means are shown as horizontal lines. (D) Bar graph 
showing I-SceI to I-SceI recombination frequency in the presence and absence of 53BP1, determined by nine independent PCR experiments. Error bars 
indicate standard deviation. The p-value was calculated using a two-tailed paired Student’s t test. FSC, forward scatter.JEM VOL. 207, April 12, 2010 
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Inhibition of ATM kinase decreases resection
DNA end resection by combined action of MRN, CtIP, 
Bloom’s helicase, and Exo1 is essential for HR (Mimitou 
and Symington, 2009). Optimal resection and formation 
of the single-stranded DNA (ssDNA) substrate for HR requires 
ATM, because this kinase facilitates the recruitment and acti-
vation of the nucleases that attack DNA ends (Jazayeri et al., 
2006; You et al., 2009). Although HR does not appear to be 
involved in CSR, we investigated whether a related mecha-
nism is involved in processing DNA ends for microhomology-
based A-NHEJ.
To determine how the loss of ATM activity might affect 
the processing of I-SceI breaks, we treated IgHI-96kAID/ 
Table S5). Interestingly, all of the minimally processed joins 
showed 0–4 nt of junctional microhomology, with a mean 
of 1.5 and 2 nt for AID/ and AID/53BP1/ B cells, 
respectively, which is characteristic of C-NHEJ (Fig. 4 and 
Fig. S3). In contrast, the majority of joining events that in-
volved extensive resection (≥30 nt) used 3 nt or more of 
junctional microhomology, with a mean of 3.6 and 4 nt for 
AID/ and AID/53BP1/ B cells, respectively, indica-
tive of A-NHEJ (P < 0.0001 for AID/; P = 0.0004 for 
AID/53BP1/; Fig. 4 C and Fig. S3). These data show 
that loss of 53BP1 leads to increased resection of DNA ends, and 
that resection is associated with microhomology-mediated 
end joining irrespective of 53BP1.
Figure 3.  Loss of 53BP1 leads to increased end resection. (A) Schematic representation of IgHI-96k allele (top) with the PCR primers used to amplify 
a 336-nt recombination product, indicated as arrows (bottom). LoxP sites are indicated as red triangles, and I-SceI sites are indicated as blue circles. 
(B) Representative ethidium bromide–stained argarose gels showing PCR products obtained after I-SceI–induced recombination in IgHI-96kAID/ and 
IgHI-96kAID/53BP1/ B cells. (C) Bar graphs showing frequency of I-SceI–induced recombination products running ≤300 nt for IgHI-96kAID/ and 
IgHI-96kAID/53BP1/ B cells, determined by 12 independent PCR experiments. Error bars indicate standard deviation. The p-value was calculated using 
a two-tailed Student’s t test. (D) Dot plot showing total resection of I-SceI–infected IgHI-96kAID/ and IgHI-96kAID/53BP1/ B cells. Each dot represents 
one sequence. The p-value was calculated using a two-tailed Student’s t test. The means are shown as horizontal lines. (E) Bar graph shows the frequency 
of perfect I-SceI joins in I-SceI–infected IgHI-96kAID/ and IgHI-96kAID/53BP1/ B cells in five independent experiments. Error bars indicate standard 
deviation. The p-value was calculated using a two-tailed Student’s t test.860 53BP1 influences end-joining pathway choice | Bothmer et al.
section in IgHI-96kAID/53BP1/ B cells (18.1% ATMi 
treated vs. 51.6% untreated IgHI-96kAID/53BP1/ control; 
P = 0.0003; Fig. 5, C and D; and Tables S3 and S7) and a con-
comitant increase in precise I-SceI joins (34.2% ATMi vs. 13.3% 
untreated control; P = 0.0021; Fig. 5 E; and Tables S5 and S8). 
Thus, the increase in I-SceI–induced DNA end processing 
observed in the absence of 53BP1 is dependent on ATM.
Loss of 53BP1 interferes with CSR but enhances recom-
bination between repeat DNA within switch regions (Manis 
et al., 2004; Ward et al., 2004; Ramiro et al., 2006; Reina-
San-Martin et al., 2007). Because the latter requires DNA 
end processing, we examined whether inhibition of DNA 
end processing by ATMi might enhance CSR in 53BP1/ 
B cells. In agreement with published studies (Lumsden et al., 
2004; Reina-San-Martin et al., 2004; Callén et al., 2007), 
ATMi reduces CSR to IgG1 in WT B cells (11.6% ATMi vs. 
21.5% untreated control; P = 0.0004; Fig. 6, A and B; and 
Table  S9).  In  striking  contrast,  ATMi  enhanced  CSR  in 
53BP1/ B cells (3.2% ATMi vs. 1.3% untreated controls;   
P = 0.0012; Fig. 6, A and B; and Table S9). We conclude 
that ATMi ameliorates the severe defect in CSR observed in 
the absence of 53BP1.
DISCUSSION
DSBs are dangerous lesions, which, if left unrepaired, can 
lead to genomic instability and genome rearrangements. These 
potentially cytotoxic lesions are repaired either by HR, which 
is conservative and error free, or by NHEJ, which fre-
quently leads to deletions and insertions. NHEJ is mediated 
by at least two separate pathways: C-NHEJ, which does not 
require DNA end resection and produces direct joins with 
little or no microhomology (Lieber, 2008), and A-NHEJ, 
which is a robust alternative pathway that makes extensive 
use of microhomology and therefore requires resection of 
ends (Haber, 2008). Of the two NHEJ pathways, C-NHEJ is 
the more conservative because there is no obligatory loss of 
genetic material.
DSBs can be repaired with a high degree of fidelity 
during the S and G2 phases of the cell cycle by HR, which 
uses the undamaged sister chromatid as a template for re-
pair. HR requires 5 to 3 resection of DNA ends to pro-
duce ssDNA, which recruits replication protein A, leading 
to deposition of Rad51, a factor that is essential in homol-
ogy search (Sung and Klein, 2006). End resection is be-
lieved  to  occur  during  two  stages:  in  the  first  phase, 
relatively short stretches of ssDNA are produced by the 
combined action of MRN and CtIP; in the second phase, 
longer stretches of ssDNA are produced by the combined 
action of Bloom’s helicase and Exo1 (Sartori et al., 2007; 
Gravel  et  al.,  2008;  Mimitou  and  Symington,  2008;   
Nimonkar et al., 2008; Zhu et al., 2008; Rass et al., 2009; 
Xie et al., 2009). ATM is implicated as a regulator of the 
resection process because it phosphorylates all of the en-
zymes known to be involved in resection (Cortez et al., 
2001), and is required for optimal ATR activation and for 
CtIP recruitment to DNA ends (Cuadrado et al., 2006; 
B cells with a small molecule ATM inhibitor (ATMi). In con-
trast to loss of 53BP1, ATMi did not significantly affect 
the joining rate of paired I-SceI breaks on the IgH locus, as 
measured by flow cytometry (Fig. 5, A and B; and Table S6). 
However, ATMi-treated IgHI-96kAID/ B cells showed sig-
nificantly reduced DNA end resection (17.8% ATMi vs. 
34.1% control; P = 0.0024; Fig. 5, C and D; and Tables S3 
and S7) and a concomitant increase in the number of precise 
I-SceI joins (47.6% ATMi treated vs. 30.9% control; P = 0.026; 
Fig. 5 E; and Tables S5 and S8).
To determine whether the increased end resection in   
the absence of 53BP1 is ATM dependent, we examined   
end resection in ATMi-treated IgHI-96kAID/53BP1/ 
B cells. ATMi induced a pronounced decrease in end re-
Figure 4.  Resected DSBs are joined using microhomology-mediated 
end joining independently of 53BP1. (A) Bar graph shows micro-
homology at junctions of PCR products cloned from I-SceI–infected  
IgHI-96kAID/ B cells. White bars indicate sequences with little resection 
(<30 nt), and black bars indicate sequences with resection ≥30 nt. A total 
of 67 individual sequences were analyzed from three different mice.  
(B) Bar graph shows microhomology at junctions of PCR products cloned 
from I-SceI–infected IgHI-96kAID/53BP1/ B cells. White bars indicate 
sequences with little resection (<30 nt), and black bars indicate sequences 
with resection ≥30 nt. A total of 48 individual sequences were analyzed 
from three different mice. (C) Table indicates the mean number of nucleo-
tides of microhomology at junctions in I-SceI–infected IgHI-96kAID/ and 
IgHI-96kAID/53BP1/ B cells.JEM VOL. 207, April 12, 2010 
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level of DNA end resection (Huertas et al., 2008; Huertas 
and Jackson, 2009; Yun and Hiom, 2009).
In the absence of a template sister chromatid during   
CSR in G1, DSBs are repaired by error-prone C-NHEJ or 
Jazayeri et al., 2006; Myers and Cortez, 2006; Sung and 
Klein, 2006). Recent work from several laboratories indi-
cates that the critical choice between HR and NHEJ in 
the S/G2/M phases of the cell cycle is regulated at the 
Figure 5.  Increased DNA end resection in the absence of 53BP1 is dependent on ATM. (A) Representative flow cytometry experiment showing CSR 
to IgG1 by IgHI-96kAID/ B cells infected with an I-SceI–encoding retrovirus in the presence or absence of ATMi. (B) Graph shows the results of three inde-
pendent flow cytometry experiments, with each dot representing an individual experiment. The means are shown as horizontal lines. (C) Representative 
ethidium bromide–stained argarose gels showing the PCR amplification products after I-SceI–induced recombination of IgHI-96kAID/ and IgHI-96kAID/ 
53BP1/ B cells in the presence or absence of ATMi. (D) Bar graph showing the frequency of I-SceI–induced recombination products running ≤300 nt for 
IgHI-96kAID/ and IgHI-96kAID/53BP1/ B cells in the presence or absence of ATMi. Error bars indicate standard deviation. p-values were calculated using 
a two-tailed Student’s t test (three independent experiments). (E) Frequency of direct I-SceI joins, reconstituting an I-SceI site, determined by sequencing of 
individual molecular products of I-SceI–infected IgHI-96kAID/ and IgHI-96kAID/ 53BP1/ B cells in the presence or absence of ATMi. Error bars indicate 
standard deviation. p-values were calculated using a two-tailed Student’s t test (three independent sequencing experiments). FSC, forward scatter.862 53BP1 influences end-joining pathway choice | Bothmer et al.
on long-range joining, which is strongly supported by our 
data, is that this protein disfavors short-range joining between 
repetitive sequences in the switch region by blocking the 
processing of DNA ends. Specifically, end processing is essential 
for the production of the ssDNA required for microhomol-
ogy-based A-NHEJ. Therefore, by interfering with end pro-
cessing, 53BP1 normally impairs A-NHEJ, which leads to 
enhanced C-NHEJ. Conversely, loss of 53BP1 favors ISDs 
by  enhancing  resection-dependent  A-NHEJ  and  disfavors 
C-NHEJ–dependent long-range recombination between two 
nonhomologous switch regions. Consistent with this idea, 
inhibition of end resection by interfering with ATM activity 
enhances CSR in 53BP1-deficient B cells.
However, a switch from C-NHEJ to A-NHEJ is not 
likely to account for the profound defect in CSR in 53BP1 
mutant B cells, as there is persistent CSR at up to 50% of nor-
mal levels despite increased ISDs in the complete absence 
of C-NHEJ (Yan et al., 2007; Han and Yu, 2008; Boboila 
et al., 2010a,b). We therefore propose a model in which 
53BP1 has two roles in CSR: it favors synapsis between distal 
DSBs and also interferes with end resection and A-NHEJ. 
Alternatively, the rapid formation of a synapse in the presence 
of 53BP1 could prevent nuclease access and extensive DNA 
end resection. Conversely, absence of 53BP1 would lead 
to prolonged access of nucleases, leading to excessive DNA 
end resection and A-NHEJ, and decreased CSR. Mechanisti-
cally, 53BP1 could block DNA end resection either directly 
by binding to H4K20me2 in the vicinity of the DSB or by   
acting as an adaptor that mediates the recruitment of addi-
tional factors, which in turn would prevent nuclease access. 
The combined effect of 53BP1 on synapsis and DNA end   
resection may explain why the absence of 53BP1 leads to 
a more pronounced defect in CSR than other DNA damage 
response factors.
Like the choice between HR and NHEJ during the S and 
G2 phases of the cell cycle (Huertas et al., 2008; Huertas and 
Jackson, 2009; Yun and Hiom, 2009), DNA end resection 
A-NHEJ. However, little is known about the choice be-
tween C-NHEJ and A-NHEJ. Under physiological circum-
stances, the majority of switch joins are blunt or show minimal 
microhomology, suggesting that C-NHEJ is the dominant 
pathway (Stavnezer et al., 2008). Nevertheless, A-NHEJ is a 
robust pathway that can reconstitute up to 50% of normal 
levels of CSR in the absence of core C-NHEJ factors such as 
ligase IV, XRCC4, or Ku70/80, or even the combination of 
Ku70 and ligase IV (Corneo et al., 2007; Yan et al., 2007; 
Boboila et al., 2010a,b).
A-NHEJ  can  also  mediate  plasmid  recircularization  in 
transfected cells (Kabotyanski et al., 1998), joining of I-SceI 
breaks (Guirouilh-Barbat et al., 2007), oncogenic transloca-
tions (Zhu et al., 2002; Ramiro et al., 2006; Wang et al., 
2008, 2009), and, finally, V(D)J recombination when the 
end protection function of the RAG recombinase is disabled 
(Lee et al., 2004). However, other than the preponderance 
of microhomologies found at the junctions (Haber, 2008; 
Zha et al., 2009) and the suggestion that MRN is required   
for A-NHEJ (Deng et al., 2009; Dinkelmann et al., 2009;   
Rass et al., 2009; Xie et al., 2009), this pathway remains   
poorly defined.
In addition to NHEJ, the DNA damage response is 
also essential for physiological CSR (Jankovic et al., 2007). 
Among the factors that mediate this response, 53BP1 has the 
most profound effect on CSR and specifically affects long-
range joining between different switch regions (Manis et al., 
2004; Reina-San-Martin et al., 2007). In contrast, 53BP1-
deficient B cells show increased short-range intra-switch 
joining, which involves ligation of highly repetitive DNA 
(Reina-San-Martin et al., 2007). These observations and the 
related findings that loss of 53BP1 results in decreased V(D)J 
recombination between distal gene segments (Difilippantonio 
et al., 2008) and transchromosomal fusions of deprotected 
telomeres (Dimitrova et al., 2008) support the hypothesis that 
53BP1 plays a role in synapsis during CSR. An alternative, 
nonexclusive explanation of the dominant effect of 53BP1 
Figure 6.  Inhibition of ATM leads to partial rescue of the CSR defect in 53BP1/ B cells. (A) Representative flow cytometry experiment show-
ing CSR to IgG1 by WT and 53BP1/ B cells 96 h after LPS, IL-4, and RP105 stimulation in the presence or absence of ATMi. (B) Graph summarizes 
CSR to IgG1 by WT and 53BP1/ B cells in four independent experiments in the presence or absence of ATMi. The means are shown as horizontal lines. 
p-values were calculated using a two-tailed Student’s t test. FSC, forward scatter.JEM VOL. 207, April 12, 2010 
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inactive  I-SceI*  does  not  induce  recombination  between  I-SceI  sites.   
Fig. S3 is a summary of all junctional analysis data for IgHI-96kAID/ 
and IgHI-96kAID/53BP1/ B cells. Tables S1 and S2 are summaries of 
I-SceI–induced  recombination  frequency  by  FACS  and  PCR.  Tables 
S3–S5  show  the  resection  data  of  I-SceI–infected  IgHI-96kAID/  and 
IgHI-96kAID/53BP1/ B cells. Tables S6–S8 are summaries of joining 
frequencies  and  resection  data  of  I-SceI–infected  IgHI-96kAID/  and   
IgHI-96kAID/53BP1/ B cells in the presence of ATMi. Table S9 is a 
summary of IgG1 expression in WT and 53BP1/ B cells in the presence or 
absence of ATMi. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20100244/DC1.
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